Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Accounts Payables (2022 - 2025)

Historic Accounts Payables for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $342000.0.

  • PAVmed's Accounts Payables changed N/A to $342000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $342000.0, marking a year-over-year change of. This contributed to the annual value of $657000.0 for FY2024, which is 6321.39% down from last year.
  • According to the latest figures from Q3 2025, PAVmed's Accounts Payables is $342000.0.
  • PAVmed's Accounts Payables' 5-year high stood at $8.2 million during Q1 2022, with a 5-year trough of $342000.0 in Q3 2025.
  • Its 4-year average for Accounts Payables is $2.0 million, with a median of $1.3 million in 2023.
  • In the last 5 years, PAVmed's Accounts Payables tumbled by 8472.37% in 2023 and then soared by 1804.45% in 2024.
  • Quarter analysis of 4 years shows PAVmed's Accounts Payables stood at $2.7 million in 2022, then plummeted by 33.95% to $1.8 million in 2023, then crashed by 63.21% to $657000.0 in 2024, then plummeted by 47.95% to $342000.0 in 2025.
  • Its last three reported values are $342000.0 in Q3 2025, $387000.0 for Q2 2025, and $369000.0 during Q1 2025.